FIGO recognises the urgent need for safe and effective preventive measures against epithelial ovarian cancer—one of the most ...

In recognition of the prognostic importance of the retroperitoneal spread of ovarian cancer, the FIGO staging classification was amended in 1988 to include a substage for nodal involvement [4].

Ovarian cancer represents the leading cause of gynecological cancer-related mortality worldwide, which could be substantially attributed to its delayed diagnosis. Indeed, most patients typically ...

The study enrolled a total of 134 patients with advanced ovarian cancer (FIGO stage IIb-IV). Weekly paclitaxel and carboplatin were administered in three blocks; an initial dose of 100 mg/m 2 ...

Seventy-seven patients with TC-resistant ovarian cancer were enrolled. Resistance to TC was defined as disease progression under treatment, absence of response after 6 cycles of TC, or early ...

Staging is surgical, according to the FIGO staging scheme, common to epithelial tumours ... 2 The current standard treatment of ovarian cancer consists of primary debulking surgery followed by ...